Review
The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs
Harold Kalant
CMAJ October 02, 2001 165 (7) 917-928;
Harold Kalant
Dr. Kalant is Professor Emeritus, Department of Pharmacology, University of Toronto, and Addiction Research Foundation Division, Centre for Addiction and Mental Health, Toronto, Ont.
Data supplements
This item has the following additional materials available:
Related Articles
In this issue
CMAJ
Vol. 165, Issue 7
2 Oct 2001
Article tools
Respond to this article
The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs
Harold Kalant
CMAJ Oct 2001, 165 (7) 917-928;
Jump to section
Related Articles
Cited By...
- Unlocking the Potential of High-Quality Dopamine Transporter Pharmacological Data: Advancing Robust Machine Learning-Based QSAR Modeling
- Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
- MDMA-Associated Liver Toxicity: Pathophysiology, Management, and Current State of Knowledge
- Stroboscopic light effects during electronic dance music festivals and photosensitive epilepsy: a cohort study and case report
- Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans
- Critical Role of Peripheral Vasoconstriction in Fatal Brain Hyperthermia Induced by MDMA (Ecstasy) under Conditions That Mimic Human Drug Use
- Urinary Excretion Kinetics of 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) and Its Phase I and Phase II Metabolites in Humans following Controlled MDMA Administration
- Investigation on the Enantioselectivity of the Sulfation of the Methylenedioxymethamphetamine Metabolites 3,4-Dihydroxymethamphetamine and 4-Hydroxy-3-Methoxymethamphetamine using the Substrate-Depletion Approach
- Metabolism and Disposition of 3,4-Methylenedioxymethamphetamine ("Ecstasy") in Baboons after Oral Administration: Comparison with Humans Reveals Marked Differences
- Ecstasy-induced thyrotoxic periodic paralysis
- The Role of Human UDP-Glucuronyltransferases on the Formation of the Methylenedioxymethamphetamine (Ecstasy) Phase II Metabolites R- and S-3-Methoxymethamphetamine 4-O-Glucuronides
- The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic 3,4-Methylenedioxyethylamphetamine and Its Single Enantiomers
- The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic 3,4-Methylenedioxy-Methamphetamine and Its Enantiomers
- Negative-Ion Chemical Ionization Gas Chromatography-Mass Spectrometry Assay for Enantioselective Measurement of Amphetamines in Oral Fluid: Application to a Controlled Study with MDMA and Driving Under the Influence Cases
- Seizures and substance abuse: Treatment considerations
- Nightclubs and the seven deadly sins
- Drug Testing in Blood: Validated Negative-Ion Chemical Ionization Gas Chromatographic-Mass Spectrometric Assay for Enantioselective Measurement of the Designer Drugs MDEA, MDMA, and MDA and Its Application to Samples from a Controlled Study with MDMA
- Pharmacological Characterization of Ecstasy Synthesis Byproducts with Recombinant Human Monoamine Transporters
- Brain Hyperthermia Is Induced by Methamphetamine and Exacerbated by Social Interaction